Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05554094 · ClinicalTrials.gov registry record · Phase 2
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
A Phase 2 study of PTSD and Stress Disorders, Post-Traumatic, sponsored by Ohio State University.
- Active
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05554094: Active Phase 2 study of PTSD and Stress Disorders, Post-Traumatic, sponsored by Ohio State University.
NCT05554094 is a Phase 2 study of PTSD and Stress Disorders, Post-Traumatic that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 15 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05554094, a Phase 2 study of PTSD and Stress Disorders, Post-Traumatic, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.
Primary Outcome
The primary clinician/session facilitator for each participant will identify/record adverse effects (i.e. the emergence of any untoward physical or psychological events or symptoms) and safety concerns at each study visit. The type, severity, and frequency of adverse events will be collected in order to identify and characterize any safety concerns that may arise. Relationship to study drug will also be reported
Conditions Studied
Interventions
- DRUG Psilocybin
Study Locations (1)
Ohio
- Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 2 |
What the registry record for NCT05554094 still lists
NCT05554094 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Psilocybin is the first listed.
NCT05554094 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05554094 about?
NCT05554094 is a clinical study titled "Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder". The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.
What is the current status of trial NCT05554094?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2023-01-01. Estimated completion is 2026-07-31.
What conditions does trial NCT05554094 study?
This clinical trial studies the following conditions: PTSD, Stress Disorders, Post-Traumatic, Mental Disorder, Trauma and Stressor Related Disorders, Stress Disorders, Traumatic.
What interventions are being tested in trial NCT05554094?
The interventions under investigation include: Psilocybin (DRUG).
Who is sponsoring clinical trial NCT05554094?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05554094 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05554094's enrollment target sits among peer trials
15 147th of 154 higher than 7 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
RECRUITING · Phase 2
-
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
RECRUITING · Phase 2
-
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
RECRUITING · Phase 2
-
Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder
RECRUITING · Phase 2
-
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
RECRUITING · Phase 2
-
Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI